2-Quinolineethanamine, also known by its IUPAC name, is an organic compound characterized by the presence of a quinoline ring fused to an ethylamine side chain. This compound typically exhibits properties associated with both aromatic and amine functionalities, which can influence its reactivity and solubility. It is generally a pale yellow to brown solid at room temperature and may have a distinct odor. The presence of the quinoline moiety suggests potential biological activity, as many quinoline derivatives are known for their pharmacological properties, including antimicrobial and antimalarial effects. The amine group can participate in hydrogen bonding, enhancing its solubility in polar solvents. Additionally, 2-Quinolineethanamine may undergo various chemical reactions, such as alkylation or acylation, due to the nucleophilic nature of the amine. Its applications may extend to medicinal chemistry, where it could serve as a scaffold for drug development or as an intermediate in the synthesis of more complex molecules. Safety data should be consulted for handling and exposure guidelines, as with any chemical substance.

2-Quinolineethanamine

104037-38-9: Quinoline,2-(2-aminoethyl)- (6CI), D 1997

2-(Quinolin-2-yl)ethanamine is a vasoconstrictor that acts by inhibiting the release of serotonin and 5-hydroxytryptamine, which are neurotransmitters that regulate blood pressure. It is used to treat carotid artery disease, but can also be used in the treatment of conditions such as peripheral vascular disease and Raynaud's phenomenon. 2-(Quinolin-2-yl)ethanamine has been shown to increase blood flow to the saphenous vein in patients with peripheral vascular disease. The drug is given intravenously in infusions, with a dose that varies depending on the condition being treated.

CAS 104037-38-9: 2-Quinolineethanamine

2-(Quinolin-2-yl)ethanamine

Ref: 3D-EEA03738

2-(Quinolin-2-yl)ethanamine

Ref: IN-DA007F44

2-(Quinolin-2-yl)ethanamine

Ref: 10-F319730